India expects biggest share of U.S. doses of AstraZeneca vaccine -govt sources Reuters 2 hrs ago
By Rupam Jain
April 27 (Reuters) - India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources told Reuters, as New Delhi battles a devastating surge in infections.
On Monday, the White House said 10 million doses could be cleared for export in coming weeks and the rest by June. It has not revealed potential beneficiaries, but the sources said India could gain the most. The wheels of diplomacy and appeals from WHO and top public health experts changed their thinking and now we have the U.S. ready to send vaccines, said one of the sources, an aide to Prime Minister Narendra Modi.
Updated:
60 million doses of AstraZeneca’s vaccine are to be shared globally
Share Article
AAA
Vital supply: The White House said 10 million doses could be cleared for export “in coming weeks” and the rest by June.
60 million doses of AstraZeneca’s vaccine are to be shared globally
India expects to secure the biggest chunk of the 60 million AstraZeneca COVID-19 vaccine doses that the United States will share globally, two Indian government sources told Reuters, as New Delhi battles a devastating surge in infections.
On Monday, the White House said 10 million doses could be cleared for export “in coming weeks” and the rest by June. It has not revealed potential beneficiaries, but the sources said India could gain the most.